A team from The Scripps Research Institute based in the US worked on a derivative of carnosic acid, a molecule found in ...
Alnylam announced the FDA approval of its supplemental new drug application for vutrisiran, an RNA interfering small molecule ...
Scientists are trying to tackle Alzheimer's from all angles, and a new study adds to the growing evidence that semaglutide, a ...
An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...
Medication options are available to help manage the cognitive and behavioral symptoms of dementia and Alzheimer's disease.
The people involved in the study have rare genetic mutations, making it nearly certain they will develop Alzheimer's. AP reports on how mass firings and funding restrictions at the NIH are affecting ...
The pursuit of a cure for Alzheimer's disease is becoming an increasingly competitive and contentious quest with recent years ...
Weekly subcutaneous administration of sabirnetug was well-tolerated in the Phase 1 study Systemic exposure following subcutaneous administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results